Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study

NCT07282132 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Polycytemia Vera

Interventions

DRUG: Ropeginterferon alfa-2b (BESREMi®)

Sponsor

Federico II University